Aguirre Daniel, Pincetti Christian, Perez Luis, Deck Carlos, Alfaro Mario, Vergara Maria Jesus, Maluenda Gabriel
San Borja Arriaran Hospital and University of Chile, Santiago, Región Metropolitana, Chile.
Clinica Alemana de Santiago, Vitacura, Región Metropolitana, Chile.
Catheter Cardiovasc Interv. 2018 Feb 1;91(2):356-361. doi: 10.1002/ccd.27246. Epub 2017 Aug 24.
This registry aimed to describe the safety and feasibility of a single trans-septal (TS) access technique for left intracardiac echocardiography (ICE) guidance of left-atrial appendage (LAA) closure procedure.
LAA closure is currently accepted as an alternative to oral anticoagulation (OAC) in patients with non-valvular atrial fibrillation (NVAF) who are at high-risk for bleeding. Currently, LAA closure procedure is typically performed under trans-esophageal echocardiogram (TEE) guidance. Although, ICE has the advantage of not requiring profound sedation/anesthesia, ICE-LAA imaging quality is often limited from the right atrium requiring double TS access.
Twenty-two patients with NVAF underwent LAA closure using the Amplatzer Amulet™ device (St Jude Medical) under ICE guidance from the left atrium. The ICE AcuNav catheter (Biosense Webster) and the Amulet delivery sheath were advanced into the LA through single TS puncture technique.
The population was predominately male (59.1%) with a mean age of 74 ± 9.3 years, at high-risk for stroke (mean CHADS2 score of 3.8 ± 1.1) and bleeding (mean HAS BLED score of 3.5 ± 1.3). The Amplatzer Amulet device was successfully implanted in all patients. No procedural related complications including device embolization were noted. No major cardiovascular events occurred and all patients were discharged alive. At 30-day follow-up all patients remained alive, free of ischemic stroke and with no residual leak or device thrombus on TEE.
This initial experience suggests that LAA occlusion with the Amplatzer Amulet device using ICE guidance from the left atrium via a single trans-septal technique is feasible and safe.
本注册研究旨在描述一种用于经心腔内超声心动图(ICE)引导下左心耳(LAA)封堵术的单穿间隔(TS)入路技术的安全性和可行性。
对于非瓣膜性心房颤动(NVAF)且出血风险高的患者,目前LAA封堵术被认为是口服抗凝治疗(OAC)的替代方法。目前,LAA封堵术通常在经食管超声心动图(TEE)引导下进行。尽管ICE具有无需深度镇静/麻醉的优势,但从右心房进行ICE-LAA成像质量往往受限,需要双TS入路。
22例NVAF患者在经左心房ICE引导下,使用Amplatzer Amulet™ 装置(圣犹达医疗公司)进行LAA封堵。通过单TS穿刺技术将ICE AcuNav导管(百盛韦伯斯特公司)和Amulet输送鞘管推进至左心房。
研究人群以男性为主(59.1%),平均年龄74±9.3岁,卒中风险高(平均CHADS2评分为3.8±1.1),出血风险高(平均HAS BLED评分为3.5±1.3)。所有患者均成功植入Amplatzer Amulet装置。未观察到包括装置栓塞在内的与手术相关的并发症。未发生重大心血管事件,所有患者均存活出院。在30天随访时,所有患者均存活,无缺血性卒中,TEE检查无残余分流或装置血栓形成。
这一初步经验表明,通过单穿间隔技术在经左心房ICE引导下使用Amplatzer Amulet装置进行LAA封堵是可行且安全的。